Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 1.75M | 1.30M | 839.80K | 519.70K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 1.91M | 1.37M | 875.80K | 673.00K | |
| Operating Income | -1.91M | -1.37M | -875.80K | -673.00K | |
| Income Before Tax | -1.90M | -1.24M | -784.50K | -666.40K | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -1.90M | -1.24M | -784.50K | -666.40K | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -1.90M | -1.24M | -784.50K | -666.40K | |
| EBIT | -1.91M | -1.37M | -875.80K | -673.00K | |
| EBITDA | -1.90M | -1.35M | -863.30K | -660.90K | |
| EPS Basic | -0.07 | -0.05 | -0.03 | -0.03 | |
| Normalized Basic EPS | -0.04 | -0.03 | -0.02 | -0.02 | |
| EPS Diluted | -0.07 | -0.05 | -0.03 | -0.03 | |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.02 | -0.02 | |
| Average Basic Shares Outstanding | 27.98M | 27.49M | 27.20M | 26.65M | |
| Average Diluted Shares Outstanding | 27.98M | 27.49M | 27.20M | 26.65M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |